Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Mar 24;16(3):e0248267. doi: 10.1371/journal.pone.0248267

Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissue

Takahide Kuwano 1, Hironori Izumi 2, Muhammad Rahil Aslam 1, Yoshiko Igarashi 1, Muhammad Bilal 1, Ayumi Nishimura 1, Yoshiyuki Watanabe 1, Allah Nawaz 1, Tomonobu Kado 1, Koichi Ikuta 3, Seiji Yamamoto 4, Masakiyo Sasahara 4, Shiho Fujisaka 1, Kunimasa Yagi 1, Hisashi Mori 2, Kazuyuki Tobe 1,*
Editor: Nobuyuki Takahashi5
PMCID: PMC7990287  PMID: 33760832

Abstract

Meflin (Islr) expression has gained attention as a marker for mesenchymal stem cells, but its function remains largely unexplored. Here, we report the generation of Meflin-CreERT2 mice with CreERT2 inserted under the Meflin gene promoter to label Meflin-expressing cells genetically, thereby enabling their lineages to be traced. We found that in adult mice, Meflin-expressing lineage cells were present in adipose tissue stroma and had differentiated into mature adipocytes. These cells constituted Crown-like structures in the adipose tissue of mice after high-fat diet loading. Cold stimulation led to the differentiation of Meflin-expressing lineage cells into beige adipocytes. Thus, the Meflin-CreERT2 mouse line is a useful new tool for visualizing and tracking the lineage of Meflin-expressing cells.

Introduction

White adipose tissue (WAT) is responsible for the storage and release of energy in response to environmental changes. Excess energy from excessive diets has led to obesity and a rapid increase in the number of people suffering from diabetes and other diseases [1,2]. Understanding the development of adipose tissue and its responses to environmental changes is important. Adipose tissue grows in two manners: the adipocyte cells themselves grow in size, and the number of adipocytes increases. Increases in the number of adipocytes can occur through the clonal proliferation of mature adipocytes and the differentiation of preadipocytes, which are the precursor cells of adipocytes [3]. The mechanism of differentiation from mesenchymal stem cells, which are thought to be more immature than preadipocytes, to the adipocyte lineage is still unclear.

Meflin (Islr) expression has received much attention as a marker for mesenchymal stem cells. Meflin has a leucine-rich repeat and immunoglobulin sequence and is located on the cell membrane at a glycosylphosphatidylinositol anchor [4]. During early development (E10), Meflin is not expressed in the nervous system and is only expressed in the mesenchymal tissue of the head and trunk [5]. Meflin (mesenchymal stromal cell- and fibroblast-expressing Linx paralogue) was in fact named for its potential usefulness as a marker of mesenchymal stem cells [4].

In recent years, the gene expression patterns of preadipocytes and more immature cells in adipose tissue have been analyzed and clarified at the single cell level. Single-cell RNA sequencing analyses of the stromal vascular fraction (SVF) in multiple types of WAT have shown that the common features of cell populations expressing Meflin are an undifferentiated state, high levels of proliferation markers, and the presence of stromal cell characteristics [68]. However, the involvement of Meflin in adipose tissues has not been studied.

We generated Meflin-CreERT2 mice under the assumption that Meflin might play an important role in the development and formation of adipose tissue. Tamoxifen induces Cre enzymes at any point in time, enabling genetic modification. Lineage tracing can therefore be performed by crossing these mice with a reporter mouse. We analyzed how mesenchymal stem cells and their progeny differentiate into cells in adipose tissue in adults. In vivo, Meflin-expressing lineage cells differentiated into mature adipocytes and constituted Crown-like structures (CLS). In addition, Meflin-expressing lineage cells were found in multivesicular, brownish-toned cells, suggesting their differentiation into cells that were thought to be beige adipocytes.

Materials and methods

Ethics statement

The use of animals was approved by the University of Toyama’s Animal Laboratory Facility and Use Committee. All the experiments were performed in accordance with the relevant guidelines and regulations and were approved by the Committee for Institutional Animal Care and Use of the University of Toyama, Toyama, Japan (License No. A2018med-355/A2018MED-52).

Mice

Mice were given free access to food and water and were kept under standard laboratory conditions. C57BL/6J wild-type mice and ROSAmTmG mice (Jax 007676) [9] were purchased from The Jackson Laboratory (USA). Rosa26-CAG-lox-stop-lox-tdTomato (Rosa26-tdTomato) mice [10] were provided by Dr. Kouichi Ikuta (Kyoto University). Genotyping of the purchased mouse strains was performed using the PCR primers and protocols provided by the supplier. Meflin-CreERT2 mice were crossed with a Cre-dependent reporter line. Mice were fed a standard rodent chow at ambient temperature (24°C) under a 12-hour light-dark cycle. Meflin-CreERT2/Rosa26-tdTomato mice and Meflin-CreERT2/ROSAmTmG mice were fed a high-fat diet (Research Diets, Cat# D12492) for eight weeks. For cold stimulation, tamoxifen-administered mice were placed in conventional cages and then subjected to 6°C for 48 h using a rodent incubator [11].

Construction of BAC-Tg Meflin-CreERT2

The plasmid pCAG-CreERT2 [12] was obtained from Addgene (Cat# 14797). We constructed a CreERT2 DNA fragment containing 5’ and 3’ homology arms derived from the Meflin genomic sequence using high-fidelity PCR and recombinant DNA methods. The resulting DNA fragment was inserted at the translational initiation Met of the mouse Meflin gene in a bacterial artificial chromosome (BAC) genomic clone (B6Ng01-165L10) using high-efficiency counterselection recombineering [13] to yield pTg-Meflin-CreERT2.

Generation of BAC Meflin-CreERT2 transgenic mouse strains

Purified pTg-Meflin-CreERT2 BAC DNA was microinjected into the pronuclei of fertilized one-cell embryos from C57BL/6 mice. Founder mice were crossed with C57BL/6 mice to produce +/Meflin-CreERT2 mice. For the genotyping of the Tg mouse lines using a Southern blot analysis, genomic DNA prepared from a tail biopsy was digested with SphI, separated by electrophoresis on a 0.8% agarose gel, and transferred to a nylon membrane Hybond-N+(Cytiva, Cat# RPN2222B). Hybridization was conducted with a 1286-bp 32P-labeled DNA fragment derived from the open reading frame of Meflin. The detected band sizes in endogenous and transgenic genes were 2.9 kb and 4.9 kb, respectively. Semi-quantification of bands in Southern blot was conducted using ImageJ software. An image file was imported, and the color tone was inverted. An area of the bund was measured in the form of a square and its average intensity was measured. The average intensity value of the measured the band was subtracted by the background value and used for comparison.

Genotyping

Routine genotyping of Meflin-CreERT2 mice was performed using PCR. Mouse tails were biopsied, and genomic DNA was extracted. The PCR enzyme was Tks Gflex DNA Polymerase (TaKaRa, Cat# R060A). The sequence of the forward primer was CCAGCTAAACATGCTTCATCGT, and the sequence of the reverse primer was TCGCTCGACCAGTTTAGTTACC. These primers yielded a PCR product of 391 bp in the Meflin-CreERT2 allele. The PCR conditions (Touchdown PCR) [14] were set as follows: 1 cycle of 2 min at 94°C; 10 cycles of 20 s at 94°C, 30 s at 65°C (reduced by -0.5°C per cycle), and 30 s at 68°C; 28 cycles of 15 s at 94°C, 15 s at 60°C, and 30 s at 72°C; and 1 cycle of 2 min at 72°C.

Tamoxifen administration

Tamoxifen (Sigma-Aldrich, Cat# T5648) was dissolved in sunflower seed oil (Wako, Cat# 196–15265), shaken and stirred overnight at 37°C, and stored at 4°C in a shaded environment (22.5 mg/mL). Tamoxifen was administered orally to 6-week-old mice at a dosage of 0.225 mg/g body weight per day for 5 consecutive days [15]. Tissues were collected 1 day, 4 weeks, or 8 weeks after tamoxifen administration.

Immunohistochemistry

Tissues were soaked in 4% paraformaldehyde at 4°C and fixed overnight. The samples were then soaked in 30% sucrose/PBS and stored overnight at 4°C. Finally, the samples were embedded in OCT compound (Sakura Finetek, Cat# 45833) and frozen at -80°C in a deep freezer. The frozen blocks were sliced to 10–20 μm on a cryostat (CM3050S, Leica) [16]. WAT was fixed in 4% paraformaldehyde and embedded in paraffin wax. Paraffin-embedded blocks were sectioned to 5-μm using a microtome (REM710, Yamato). Immunohistochemistry was performed on frozen sections or paraffin sections using standard protocols. Primary antibodies were applied to the sections and incubated overnight at 4°C. Secondary antibodies were used against the host animals corresponding to the primary antibody. The primary antibodies were goat polyclonal anti-tdTomato antibody (1:100; ORG Origene Technologies, Cat# AB8181-200), rabbit polyclonal anti-UCP-1 antibody (1:500; Abcam, Cat# ab10983), rabbit polyclonal anti-Perilipin antibody (1:100; Santa Cruz Biotechnology, Cat# sc-67164), and rat monoclonal anti-F4/80 FITC conjugated antibody (1:500; Abcam, Cat# ab60343). The secondary antibodies were Alexa Fluor-488 donkey anti-rabbit (1:500, Life Technologies, Cat# A-21206) and Alexa Fluor-594 donkey anti-goat (1:500, Life Technologies, Cat# A-11058). The stained slices were mounted with DAPI Fluoromount-G (SBA Southern Biotechnology, Cat# 0100–20). AlexaFluor 488 phalloidin (Invitrogen, Cat# R37110) was used to stain for F-actin and to visualize the cytoskeleton in the frozen sections. The sections were imaged using an Olympus BX61/DP70 and a Zeiss LSM780 confocal microscope.

Wholemount and confocal imaging

Adipose depots were dissected and cut into 0.5 × 0.5 × 0.2-cm blocks. These blocks were mounted onto slides with Fluoromount (Diagnostic BioSystems, Cat# K024) and imaged using a Zeiss LSM780 confocal microscope [17]. Brightness and contrast were adjusted to improve the visibility of the cell membranes, and EGFP+/tdTomato+ adipocytes were quantified using ImageJ software [18].

Glucose tolerance test and insulin tolerance test

Oral glucose tolerance test (2 g/kg body weight) and intraperitoneal insulin tolerance test (1.0 unit/kg body weight) were performed after 4-hour and 2-hour fasting period, respectively. Blood samples were taken from the tail vein at specific times and glucose levels were measured using STAT STRIP Express 900 (Nova Biomedical, Waltham MA).

Quantitative real-time PCR

Total RNA was extracted with RNeasy mini kit (QIAGEN, Cat# 74106), and complementary DNA was synthesized with PrimeScript RT Master Mix (Takara, Cat# RR036A), in accordance with the manufacturer’s protocol. Quantitative PCR of the genes was performed using TB Green Fast qPCR Mix (Takara, Cat# RR430S). Fluorescence was analyzed in the Mx3000P QPCR System (Agilent Technologies, Santa Clara, CA, USA). The thermal cycling conditions were 1 cycle at 95°C for 30 s, followed by 45 cycles of 10 s at 95°C and 30 s at 60°C. Each sample was run in duplicate. The relative mRNA levels were normalized to Tbp mRNA. The relative mRNA expression levels were calculated using the 2ΔΔCT method. Primer sequences are listed in S1 Table.

Statistical analysis

Statistical analysis was performed with JMP® 14 (SAS Institute Inc., Cary, NC, USA). The statistical significance of between-group differences was evaluated by using unpaired two-tailed Student’s t-tests. Differences among more than two groups were evaluated for statistical significance by ANOVA with the Tukey-Kramer HSD post hoc test for multiple comparisons. A P value of less than 0.05 was considered significant. Data are presented as the mean ± SEM.

Result

Generation of Meflin-CreERT2 mice

Meflin-CreERT2 transgenic mice were generated to enable the lineage tracing of mesenchymal stem cells and adipocyte progenitors. The CreERT2 coding sequence was inserted downstream of the start codon of exon 2 of the Meflin gene (Fig 1A). Meflin-CreERT2 BAC DNA was then microinjected into the pronuclei of fertilized one-cell embryos from C57BL/6 mice. Forty-three offspring mice were obtained. A Southern blot analysis confirmed that the four founder mice carried the CreERT2 allele. The transgenic and wild-type alleles were identified at 4.9 and 2.9 kb, respectively. A semi-quantitative analysis by ImageJ showed that an intensity of the 4.9 kb band was half that of the 2.9kb band, indicating that one copy of the transgene allele was inserted (Fig 1B). The heterozygous Meflin-CreERT2 mice were viable, fertile, and behaved similarly to wild-type mice. Meflin gene expression showed no difference in the adipose tissue in the presence or absence of the transgenic allele (S1A Fig).

Fig 1. Generation Meflin-CreERT2 mice.

Fig 1

a) First, BAC carrying the Meflin gene was introduced together with a zeocin resistance gene (rZeocin) downstream of the translation start point Met. Next, counter-selection using a CreERT2 fragment with the 5’ and 3’ homologous arms of the Meflin gene was performed. b) Southern blot analysis. Genomic DNA was digested with Sph1 and detected using a Meflin-ORF probe. The transgenic allele was identified at 4.9 kb, and the wild-type allele was identified at 2.9 kb.

Functional Meflin-CreERT2 activity in vivo

To evaluate the functional expression of CreERT2 in vivo throughout the whole body, Meflin-CreERT2 mice were crossed with Rosa26-tdTomato reporter mice containing the tdTomato gene, the expression of which requires the deletion of loxP-flanked stop sequences [10].

The Meflin-CreERT2/Rosa26-tdTomato transgenic mice were orally treated with tamoxifen at 6 weeks of age for 5 consecutive days. Four weeks after the treatment, the mice were sacrificed, and WAT and several other types of tissues were harvested.

In WAT, tdTomato expression was observed in mature adipocytes and brown adipocytes (Fig 2A and 2B). In skeletal muscle tissue, tdTomato expression was observed in cells located at the periphery of muscle fibers (Fig 2C). In mammary glands, tdTomato fluorescence was found in star-shaped cells surrounding the mammary ducts (Fig 2D). In the liver, fluorescence was observed in perivascular stroma that was in close proximity to a vein (Fig 2E). In the pancreas, some of the glandular cells were found to have a strong fluorescent signal (Fig 2F). In the intestine, the tdTomato signal was found throughout the cytoplasm of a portion of the monolayer columnar epithelium (Fig 2G). In the testis, expression was found in Leydig cells located in the interstitium (Fig 2H). In the kidneys, tdTomato was expressed in cells comprising the glomeruli. It was also expressed in cells with foot processes in the peritubular stroma (Fig 2I). The specificity and efficiency of recombination did not differ between male and female mice. These results revealed the recombination of CreERT2 throughout the body and the distribution of various Meflin-expressing lineage cells.

Fig 2. Expression distribution of Meflin lineage cells in vivo.

Fig 2

Organ tissues from Meflin-CreERT2/Rosa26-tdTomato mice treated with tamoxifen beginning at 6 weeks of age and fed a normal diet for 4 weeks were analyzed histologically. Nuclei were stained using DAPI (blue); staining with the F-actin marker phalloidin (green) was used to define the cytoskeleton. The tdTomato signal (red) was found in gonadal white (A) and brown (B) adipocytes. In skeletal muscle (C), mammary ducts (D), liver (E), testes (H), and kidneys (I), tdTomato expression was found in cells located in the interstitium. In the pancreas, expression was observed in glandular cells (F); expression in the kidneys was seen in cells constituting the glomerulus (I). The scale bars represent 50 μm in (B), (B’), (C), (C’), (E), (E’), (I) and (I’) and 100 μm in all the other panels. A-I: merged (tdTomato + F-Actin + DAPI), A’-I’: tdTomato.

Lineage tracing of white adipose tissue

To evaluate the distribution of Meflin-expressing lineage cells in WAT and the differentiation of preadipocytes into mature adipocytes, we analyzed WAT from Meflin-CreERT2/Rosa26-tdTomato mice fed a normal diet for 4 weeks or a high-fat diet for 8 weeks. The expression of mesenchymal stem cell (MSC) markers (including Meflin, Cd105, Sca-1) was increased in the high-fat diet-loaded mice compared to the normal diet-loaded mice (S1B Fig).

After 4 weeks of the normal diet, several Meflin-expressing lineage cells were located in the stroma between mature adipocytes. A number of cells with tdTomato fluorescence were present in the membranous structures surrounding gonadal WAT (gWAT). Meflin-expressing lineage cells mainly existed in the capsule areas surrounding the periphery of gWAT and moved from the capsule area to the internal adipose tissue. We also observed the co-staining of fluorescent signals from tdTomato and perilipin, a marker of mature adipocytes (Fig 3A and 3B).

Fig 3. Adipose tissue lineage tracing.

Fig 3

Meflin-CreERT2/Rosa26-tdTomato mice were fed a normal diet for 4 weeks (ND 4w) or a high-fat diet for 8 weeks (HFD 8w) and gonadal WAT (gWAT) samples were examined. WAT was stained with the adipocyte markers perilipin (green), tdTomato (red), and DAPI (blue). (A) ND4w gWAT is surrounded by membranous structures with tdTomato signals. Meflin-expressing lineage cells appear to have penetrated into the adipose tissue stroma (arrowhead). (B) Strong magnified image of membranous structure in ND4w gWAT. (C) HFD8w gWAT. Meflin-expressing lineage cells comprise Crown-like structure, a characteristic structure found in adipose tissue. (D) HFD8w gWAT. Small, multiporous adipocytes are visible, and tdTomato-positive cells can be seen adjacent to the cells. MeflinCreERT2/ROSAmTmG mice were loaded with a normal diet (E) and a high-fat diet (F) for 8 weeks. Whole-mounted gWAT samples were then examined. Confocal laser microscopy was used to image tdTomato-positive and EGFP-positive adipocytes. Each fluorescent cell was counted (G). Scale bars represent 50 μm in (B) and (B’) and 100 μm in all the other panels. A-D: Merged (tdTomato + Perilipin + DAPI), A’-D’: tdTomato, E-F: EGFP + tdTomato.

Inflammatory markers were elevated in mice fed a high-fat diet for 8 weeks, compared with mice fed a normal diet (S1D Fig). Transgenic expression of Meflin-CreERT2 did not affect glucose tolerance (S1E and S1F Fig). After 8 weeks of HFD treatment, tdTomato-positive and perilipin-negative cells from Meflin-expressing lineages had formed ring-shaped structures and multinucleated giant cells (Fig 3C). These ring-like structures are known as CLS. CLS are characteristic structures in which macrophages and multinucleated giant cells surround and process adipocytes that are subjected to cell death during the obesity process [19]. We confirmed that CLS in WAT co-expressed tdTomato and F4/80 (S1G Fig). Small multicellular adipocytes were also seen, and Meflin-positive cells were located adjacent to these cells (Fig 3D). To assess the contribution of Meflin-expressing lineage cells to mature white adipocytes, Meflin-CreERT2/ROSAmTmG mice were subjected to a high-fat diet for 8 weeks to stimulate differentiation from progenitor adipocytes to mature adipocytes. The normal diet-fed mice had an EGFP-positive rate of 26.7% and a tdTomato-positive rate of 73.3% (Fig 3E and 3G). In high-fat diet Mature adipocytes expressing EGFP and tdTomato-expressing cells accounted for 50.4% and 49.6% of the cell population, respectively (Fig 3F and 3G). These results suggest that in adult adipose tissues in animals fed an HFD, Meflin lineage cells constitute the CLS. However, whether these cells are adipocytes, macrophages or preadipocytes remains unknown.

Meflin lineage cells become beige like adipocytes

As shown in Fig 3D, we observed small, multi-spore-like adipocytes that were morphologically similar to beige adipocytes [20]. Beige adipocytes are brown-like adipocytes that have a multilocular morphology and express UCP1 but are found in WAT [21]. Since they are induced in WAT exposed to cold or other inducers [21], cold stimulation experiments were performed to further investigate the involvement of Meflin-expressing lineage cells in beige adipocytes. Meflin-CreERT2/Rosa26-tdTomato mice were subjected to cold stimulation at 6°C for 48 hours and inguinal WAT (iWAT) was harvested. Cold stimulation did not affect the expression of MSC marker genes including Meflin, Cd105, Sca-1 (S1C Fig). To determine the cellular characteristics, we stained iWAT with anti-UCP1 and anti-tdTomato antibodies and observed that cells with a beige-like adipocyte morphology were co-stained (Fig 4A, 4A’, 4B and 4B’). The results suggest that cold stimulation led to the differentiation of Meflin-expressing lineage cells into beige adipocytes.

Fig 4. Meflin lineage cells become beige like adipocytes.

Fig 4

Meflin-CreERT2/Rosa26-tdTomato mice were subjected to cold stimulation at 6°C for 48 h. Inguinal WAT (iWAT) was then harvested. (A, A’) Immunostaining image shows tdTomato (red)- and UCP1 (green)-positive cell masses. (B, B’) Magnified images of A and A’. The cells in the center have the morphological characteristics of beige adipocytes. Scale bars represent 100 μm in (A) and (A’) and 50 μm in (B) and (B’). A, B: Merged (UCP1 + tdTomato + DAPI), A’, B’: tdTomato.

Discussion

We generated Meflin-CreERT2 mice and traced the distribution of Meflin in both systemic tissues and WAT. We confirmed the occurrence of recombination with CreERT2 throughout the body and observed that many lineage cells were located in the stroma.

De novo adipogenesis in gWAT reportedly occurs in fibroblasts in an outer structure, known as the capsule, that surrounds adipose tissue [22]. WT1 lineage mesothelial cells have been reported as the origin of de novo adipogenesis in gWAT [23]. Our present findings were similar to these previous studies. Meflin-expressing lineage cells mainly exist in capsule areas, and the cells move from the capsule area to the internal adipose tissue. These observations suggest that Meflin-positive cells in the fibrous stroma surrounding gWAT generate new adipocytes as they migrate from outside the membrane to the inside.

We found that in mice fed a high-fat diet for 8 weeks, the CLS were composed of Meflin-expressing lineage cells in WAT. CD68 (a common macrophage marker)-positive and CD34-positive cells reportedly form a ring structure in WAT and are involved in adipocyte differentiation and proliferation [24]. Our results suggest that Meflin-expressing lineage cells constitute the CLS and are involved in the remodeling of WAT.

The origin of beige adipocytes is still unclear, but they are reportedly derived from the conversion of existing white adipocytes [25,26]. In other words, beige adipocytes are thought to differentiate from progenitor cells in white adipocytes. PDGFRa-positive cells in iWAT are thought to be the precursors of beige adipocytes [27]. We observed the presence of morphologically similar beige-like cells in iWAT after cold stimulation that were positive for both UCP1 and tdTomato. These findings suggest that Meflin is expressed in precursors, such as PDGFRa, that can differentiate into beige adipocytes.

Single cell RNA sequencing is a recent technological development that has made it possible to classify a previously unexplored population of SVFs in WAT, known as SVF progenitor adipocytes or adipose stem cells, based on the type and degree of gene expression [68]. In the present report, we observed the differentiation of Meflin-expressing lineage cells into mature adipocytes by the expression of CreERT2 in adipose tissue during the adult phase, confirming its usefulness as a marker for adipose stem cells.

A limitation of this study is that the induction of CreERT2 was limited to the adult phase. Future evaluation of adipose tissue during early development and the neonatal periods will be necessary to perform detailed studies on adipose tissue development and the lineage tracing of Meflin-expressing lineage cells.

A single cell RNA sequencing analysis in humans reported a positive effect on blood glucose when the number of retained pre-beige adipocytes, known as VPMs, was relatively high [28]. We found that Meflin-expressing lineage cells can become beige-like cells. Consequently, we would like to evaluate the effects of Meflin-positive cells and their lineage cells on adipose tissue and glucose metabolism in the future.

Supporting information

S1 Fig

A. Meflin mRNA levels in the gonadal WAT (n = 4–5). B. QPCR of mesenchymal stem cell related genes in gonadal white adipose tissues of mice treated with normal diet (ND) or high-fat diet (HFD) for 8weeks (n = 4–5). *p < 0.05 by unpaired, 2-tailed t test. C. QPCR of mesenchymal stem cell related genes in inguinal white adipose tissues of mice treated with room temperature (RT) or cold stimulation (Cold) (n = 3–4). D. QPCR of inflammation related genes in gonadal white adipose tissues of mice treated with normal diet (ND) or high-fat diet (HFD) for 8weeks (n = 4–5). E. Oral glucose tolerance test (OGTT) of HFD-fed mice for 8 weeks with the transgenic allele (n = 6) or WT allele (n = 5). F. Insulin tolerance test (ITT) of HFD-fed mice for 8 weeks with the transgenic allele (n = 3) or WT allele (n = 4). G. The Crown like structure were consisted of the cells expressing tdTomato and F4/80. Meflin-CreERT2/Rosa26-tdTomato mice were fed a high-fat diet for 8 weeks and gonadal WAT (gWAT) samples were examined. Meflin lineage cells expressed tdTomato (red) and F4/80 (green). F4/80 is a mature macrophage marker. Nuclei were stained by DAPI (blue). Scale bars represent 50 μm.

(TIF)

S1 Table. Primers used for qPCR analyses.

(PDF)

S1 Raw images

(PDF)

Acknowledgments

The plasmid pCAG-CreERT2 was a gift from Dr. Connie Cepko (Addgene plasmid # 14797). Mouse BAC clone (B6Ng01-165L10P) derived from C57BL/6N strain was kindly provided from Riken bio-resource center (Riken BRC, Tsukuba). The pABRG and pR6K-photo-rspL-bsd plasmids used for BAC recombination were provided by Dr. A Francis Stewart.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was supported by JSPS KAKENHI Grants-in-Aid for Scientific Research(B)(20H03730; https://www.jsps.go.jp/j-grantsinaid/index.html), Firstbank of toyama scholarship foundation reserch grant  (https://www.first-bank.co.jp/outline/local), the Mitsubishi foundation (201910031:https://www.mitsubishi-zaidan.jp), the Naito Foundation  (https://www.naito-f.or.jp/jp/index.php),Grant from Japan Diabetes Foundation(http://www.j-df.or.jp), the Uehara Memorial Foundation (https://www.ueharazaidan.or.jp) to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Berry R, Jeffery E, Rodeheffer MS. Weighing in on adipocyte precursors. Cell Metab. 2014;19: 8–20. 10.1016/j.cmet.2013.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti GA, et al. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci. 2019;20. 10.3390/ijms20092358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Vishvanath L, Gupta RK. Contribution of adipogenesis to healthy adipose tissue expansion in obesity. J Clin Invest. 2019;129: 4022–4031. 10.1172/JCI129191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Maeda K, Enomoto A, Hara A, Asai N, Kobayashi T, Horinouchi A, et al. Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells. Sci Rep. 2016;6: 22288. 10.1038/srep22288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Homma S, Shimada T, Hikake T, Yaginuma H. Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expr Patterns. 2009;9: 1–26. 10.1016/j.gep.2008.09.004 [DOI] [PubMed] [Google Scholar]
  • 6.Burl RB, Ramseyer VD, Rondini EA, Pique-Regi R, Lee Y-H, Granneman JG. Deconstructing Adipogenesis Induced by β3-Adrenergic Receptor Activation with Single-Cell Expression Profiling. Cell Metab. 2018;28: 300–309.e4. 10.1016/j.cmet.2018.05.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schwalie PC, Dong H, Zachara M, Russeil J, Alpern D, Akchiche N, et al. A stromal cell population that inhibits adipogenesis in mammalian fat depots. Nature. 2018;559: 103–108. 10.1038/s41586-018-0226-8 [DOI] [PubMed] [Google Scholar]
  • 8.Merrick D, Sakers A, Irgebay Z, Okada C, Calvert C, Morley MP, et al. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science (80-). 2019;364: eaav2501. 10.1126/science.aav2501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double fluorescent Cre reporter mouse. Genesis. 2007;45: 593–605. 10.1002/dvg.20335 [DOI] [PubMed] [Google Scholar]
  • 10.Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13: 133–140. 10.1038/nn.2467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Igarashi Y, Nawaz A, Kado T, Bilal M, Kuwano T, Yamamoto S, et al. Partial depletion of CD206-positive M2-like macrophages induces proliferation of beige progenitors and enhances browning after cold stimulation. Sci Rep. 2018;8: 1–10. 10.1038/s41598-017-17765-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Matsuda T, Cepko CL. Controlled expression of transgenes introduced by in vivo electroporation. Proc Natl Acad Sci U S A. 2007;104: 1027–1032. 10.1073/pnas.0610155104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bird AW, Erler A, Fu J, Hériché J-K, Maresca M, Zhang Y, et al. High-efficiency counterselection recombineering for site-directed mutagenesis in bacterial artificial chromosomes. Nat Methods. 2011;9: 103–109. 10.1038/nmeth.1803 [DOI] [PubMed] [Google Scholar]
  • 14.Korbie DJ, Mattick JS. Touchdown PCR for increased specificity and sensitivity in PCR amplification. Nat Protoc. 2008;3: 1452–1456. 10.1038/nprot.2008.133 [DOI] [PubMed] [Google Scholar]
  • 15.Horikawa S, Ishii Y, Hamashima T, Yamamoto S, Mori H, Fujimori T, et al. PDGFR α plays a crucial role in connective tissue remodeling. Nat Publ Gr. 2015; 1–14. 10.1038/srep17948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kado T, Nawaz A, Takikawa A, Usui I, Tobe K. Linkage of CD8 + T cell exhaustion with high-fat diet-induced tumourigenesis. Sci Rep. 2019; 1–8. 10.1038/s41598-019-48678-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sebo ZL, Jeffery E, Holtrup B, Rodeheffer MS. A mesodermal fate map for adipose tissue. 2018. 10.1242/dev.166801 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9: 671–675. 10.1038/nmeth.2089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46: 2347–2355. 10.1194/jlr.M500294-JLR200 [DOI] [PubMed] [Google Scholar]
  • 20.Singh AM, Zhang L, Avery J, Yin A, Du Y, Wang H, et al. Human beige adipocytes for drug discovery and cell therapy in metabolic diseases. Nat Commun. 2020;11: 2758. 10.1038/s41467-020-16340-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kajimura S, Spiegelman BM, Seale P. Brown and beige fat: Physiological roles beyond heat generation. Cell Metab. 2015;22: 546–559. 10.1016/j.cmet.2015.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Cattaneo P, Mukherjee D, Spinozzi S, Zhang L, Larcher V, Stallcup WB, et al. Parallel lineage-tracing studies establish fibroblasts as the prevailing in vivo adipocyte progenitor. Cell Rep. 2020;30: 571–582.e2. 10.1016/j.celrep.2019.12.046 [DOI] [PubMed] [Google Scholar]
  • 23.Chau Y-Y, Bandiera R, Serrels A, Martínez-Estrada OM, Qing W, Lee M, et al. Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol. 2014;16: 367–375. 10.1038/ncb2922 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, Fujita H, et al. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes. 2007;56: 1517–1526. 10.2337/db06-1749 [DOI] [PubMed] [Google Scholar]
  • 25.Wang QA, Tao C, Gupta RK, Scherer PE. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat Med. 2013;19: 1338–1344. 10.1038/nm.3324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Wu J, Boström P, Sparks LM, Ye L, Choi JH, Giang A-H, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell. 2012;150: 366–376. 10.1016/j.cell.2012.05.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lee Y-H, Petkova AP, Mottillo EP, Granneman JG. In vivo identification of bipotential adipocyte progenitors recruited by β3-adrenoceptor activation and high-fat feeding. Cell Metab. 2012;15: 480–491. 10.1016/j.cmet.2012.03.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Vijay J, Gauthier M-F, Biswell RL, Louiselle DA, Johnston JJ, Cheung WA, et al. Single-cell analysis of human adipose tissue identifies depot and disease specific cell types. Nat Metab. 2020;2: 97–109. 10.1038/s42255-019-0152-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Nobuyuki Takahashi

30 Dec 2020

PONE-D-20-35143

Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissue

PLOS ONE

Dear Dr. Tobe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 12 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Nobuyuki Takahashi, Ph.D.

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS ONE now requires that authors provide the original uncropped and unadjusted images underlying all blot or gel results reported in a submission’s figures or Supporting Information files. This policy and the journal’s other requirements for blot/gel reporting and figure preparation are described in detail at https://journals.plos.org/plosone/s/figures#loc-blot-and-gel-reporting-requirements and https://journals.plos.org/plosone/s/figures#loc-preparing-figures-from-image-files. When you submit your revised manuscript, please ensure that your figures adhere fully to these guidelines and provide the original underlying images for all blot or gel data reported in your submission. See the following link for instructions on providing the original image data: https://journals.plos.org/plosone/s/figures#loc-original-images-for-blots-and-gels.

In your cover letter, please note whether your blot/gel image data are in Supporting Information or posted at a public data repository, provide the repository URL if relevant, and provide specific details as to which raw blot/gel images, if any, are not available. Email us at plosone@plos.org if you have any questions.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors generated the tamoxifen-induced transgenic mice with Meflin, which w

as a major maker of the mesenchymal stem cell. Meflin was expressed on the crown

-like structure (CLS) in the adipose tissue of high fat diet-fed mice. The Mefli

n-expressing lineage cells were differentiated to the beige adipocytes by the co

ld exposure.

1. To what degree did Mefrin mRNA and protein expression levels increase in the

adipose tissue of Meflin transgenic mice compared to those of control mice?

2. Do other mesenchymal stem cell (MSC) markers, such as CD90, CD105 and Sca-1 e

levate in the adipose tissues of high fat diet-fed mice or after the cold exposu

re?

3. Please show the ratio of Meflin-positive cells in the adipose tissue of norma

l chow-fed mice in Figure 3F.

4. It is recommended that the authors measure the expression levels of Meflin in

UCP-1 positive cells of the adipose tissue after cold stimulation.

5. There was no description of Figure 4B’ in Result section.

6. The phenotypes of high-fat diet-fed Meflin transgenic mice, such as inflammat

ion and insulin sensitivity, are not mentioned in the text. Please specify those

phenotypes.

Reviewer #2: In this article, the authors generated Meflin-CreERT2 mice, and they performed lineage tracing using this mouse model. They showed that Meflin-expressing lineage cells exists in various tissues. In WAT, Meflin-expressing lineage cells were present in stroma and differentiated into mature adipocytes under HFD feeding condition. They also showed that Meflin-expressing lineage cells can differentiate into beige adipocytes under cold temperature. This article contains interesting findings. Please respond to the concerns listed below.

1. L120, “2 min at 4 ℃” should be “2 min at 94 ℃”.

2. The authors should determine the copy number of inserted DNA in mice used this study (Fig.2 ~) by Southern blotting.

3. Fig.2. tdTomato-derived fluorescence in some images is very weak and blurry, and it is very difficult to judge which cells are tdTomato positive cells. Especially, the fluorescence from brown adipose tissue, liver, intestine, testis, and kidney looks very weak, and it is difficult to exclude the possibility that these fluorescences are autofluorescence. The authors should show clearer images and clarify that these fluorescencea are not from autofluorescence.

4. In Fig.2, which white adipose tissue depot was used? gWAT? iWAT?

5. Fig.3. Similar to the case of Fig.2, tdTomato-derived fluorescence in some images is very weak and blurry (Fig.3A and 3B).

6. Fig.3. From the images of 3C, 3D, it looks like a very limited number of adipocytes are tdTomato positive (Meflin-expressing lineage cells). However, in Fig 3E and 3F, approximately half of the adipocytes are GFP positive, suggesting that these cells are Meflin-expressing lineage cells. The authors should explain this discrepancy.

7. L238, the author mentioned “Meflin-expressing lineage cells differentiate into mature adipocytes that constitute CLS”. However, they also showed that tdTomato-expressing cells in CLS also express F4/80, suggesting that Meflin-expressing lineage cells in CLS are macrophages. Therefore, the authors should clarify whether Meflin-expressing lineage cells in CLS are adipocytes or macrophages.

8. L261, “Fig 3C” should be “Fig 3D”.

9. Fig.4B. Similar to the case of Fig.2, tdTomato-derived fluorescence is too weak and blurry to judge whether these cells are tdTomato positive.

10. Fig.4. There is only one beige adipocyte in these images, and it is difficult to judge whether all beige adipocytes are derived from Meflin-expressing lineage cells. Thus, the authors should show images containing many beige adipocytes at a low magnification.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Mar 24;16(3):e0248267. doi: 10.1371/journal.pone.0248267.r002

Author response to Decision Letter 0


23 Feb 2021

Responses to Reviewers’ comments

To Reviewer #1:

1. To what degree did Meflin mRNA and protein expression levels increase in the adipose tissue of Meflin transgenic mice compared to those of control mice?

Response:

Thank you for your insightful question. Meflin-CreERT2 mice were generated by the microinjection of a BAC-derived targeting vector into the pronuclei of fertilized eggs. For the targeting vector, CreERT2 was inserted just below the ATG of Meflin to avoid the expression of foreign DNA-derived Meflin. Southern blotting data (Fig 1B) showed that the transgenic vector did not disrupt the endogenous Meflin gene. In fact, quantitative real-time PCR revealed no difference in the expression of Meflin in the white adipose tissue of mice with or without the transgenic allele (S1 Fig A).

We have added new data to S1 Fig A to show the profile of the Meflin gene in the mice. We have also added the following sentence to the text: “Meflin gene expression showed no difference in the adipose tissue in the presence or absence of the transgenic allele (S1 Fig A)” (Lines 203-205). We have also added two sections describing the quantitative real-time PCR method and the statistical analysis to the Experimental Methods section (Lines 172-189).

2. Do other mesenchymal stem cell (MSC) markers, such as CD90, CD105 and Sca-1 elevate in the adipose tissues of high fat diet-fed mice or after the cold exposure?

Response:

An HFD induced the expression of MSC markers including Meflin, Cd105, and Sca-1 in mice. This result may be due to the increased proliferation of adipocyte progenitors and the subsequent differentiation of preadipocytes into mature adipocytes. In contrast, cold stimulation at 6℃ for 48 h did not affect the expression of MSC markers. Thus, we have added the following sentences to the manuscript: “The expression of mesenchymal stem cell (MSC) markers (including Meflin, Cd105 and Sca-1) was increased in the high-fat diet-loaded mice, compared with the normal diet-loaded mice (S1 Fig B)” (Lines 254-256). “Cold stimulation did not affect the expression of MSC marker genes including Meflin, Cd105, and Sca-1 (S1 Fig C)” (Lines 311-313).

3. Please show the ratio of Meflin-positive cells in the adipose tissue of normal chow-fed mice in Figure 3F.

Response:

Thank you for this valuable suggestion. In Figure 3F, we counted and described the numbers of tdTomato-positive and EGFP-positive cells in the white adipose tissue of MeflinCreERT2 *mTmG mice after 8 weeks of normal diet (Fig 3F). The following statement has been added: “The normal diet-fed mice had an EGFP-positive rate of 26.7% and a tdTomato-positive rate of 73.3% (Fig 3F, G)” (Lines 274–275).

4. It is recommended that the authors measure the expression levels of Meflin in UCP-1 positive cells of the adipose tissue after cold stimulation.

Response:

As this reviewer suggested, we tried to purify UCP1-positive beige adipocytes from mice under cold stimulation according to the method described in a paper by Hagberg.1 However, we were unable to purify these cells because of limitations in the equipment that were used. Our data suggested that Meflin-positive adipocyte progenitors can differentiate into not only white adipocytes, but also UCP1-positive beige adipocytes. Meflin expression is reportedly limited to mesenchymal stem cell-like cells including adipocyte progenitors and disappears once they differentiate into mature adipocytes.2 Consistent with this report,3 a recent report on single-cell RNA profiling revealed that Meflin-positive Pi16+ progenitors did not express Ucp1.

1. Hagberg CE, et al. Flow Cytometry of Mouse and Human Adipocytes for the Analysis of Browning and Cellular Heterogeneity. Cell Rep. 2018; 24(10):2746-2756.e5.

2. Maeda K, et al. Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells. Sci Rep. 2016; 6:22288.

3. Henriques F et al. Single-Cell RNA Profiling Reveals Adipocyte to Single-Cell RNA Profiling Reveals Adipocyte to Macrophage Signaling Sufficient to Enhance Thermogenesis. Cell Rep. 2020 Aug 4;32(5):107998

5. There was no description of Figure 4B’ in Result section.

Response:

We apologize for the lack of a description. We have corrected Line 292 as follows: “To determine the cellular characteristics, we stained iWAT with anti-UCP1 and anti-tdTomato antibodies and observed that cells with a beige-like adipocyte morphology were co-stained (Fig. 4A, 4A’, 4B, 4B’)” (Lines 312-315).

6. The phenotypes of high-fat diet-fed Meflin transgenic mice, such as inflammation and insulin sensitivity, are not mentioned in the text. Please specify those phenotypes.

Response:

Thank you for your valuable insight. Data on glucose tolerance and inflammation in the adipose tissue of Meflin transgenic mice fed a high-fat diet has been added to S1 Fig E, F. In addition, we have added the following statement at Lines 263–265: “Inflammatory markers were elevated in mice fed a high-fat diet for 8 weeks, compared with mice fed a normal diet (S1 Fig D). The transgenic expression of Meflin-CreERT2 did not affect glucose tolerance (S1 Fig E, F).” We have also added sentences describing the glucose tolerance test and the insulin tolerance test used in this study to the Method section (Lines 166-170).

To Reviewer #2

1. L120, “2 min at 4 °C” should be “2 min at 94 °C”.:

Response: Thank you very much for pointing out this error. Line 120 has been corrected to “2 min at 94℃” (Line 125).

2. The authors should determine the copy number of inserted DNA in mice used this study (Fig.2 ~) by Southern blotting.

Response:

Thank you for pointing this out. Figure 1B was submitted to show the transmission of the F1 generation to the germ line using a Southern blot. However, the band of the transgenic allele appears to be fainter than that of the endogenous Meflin. This appearance may be due to an incomplete restriction enzyme treatment, which left some residues. We have replaced the results of the Southern blot experiment confirming that the founders carried the transgenes (Fig 1B). The lower and upper bands were from the endogenous Meflin allele and the transgenic allele, respectively. A semi-quantitative analysis using ImageJ showed that the intensity of the upper band was half that of the lower band, indicating that one copy of the transgene allele had been inserted.

Lines 183–185 have been revised as followings: “A Southern blot analysis confirmed that the four founder mice carried the CreERT2 allele. The transgenic and wild-type alleles were identified at 4.9 and 2.9 kb, respectively. A semi-quantitative analysis using ImageJ showed that the intensity of the 4.9 kb band was half that of the 2.9 kb band, indicating that one copy of the transgene allele had been inserted (Fig 1B)” (Lines 198-202).

In the Generation of BAC Meflin-CreERT2 transgenic mouse strains section, we have added a description of how to semi-quantify the intensity of the bands using ImageJ (Lines 110-115).

3. Fig.2. tdTomato-derived fluorescence in some images is very weak and blurry, and it is very difficult to judge which cells are tdTomato positive cells. Especially, the fluorescence from brown adipose tissue, liver, intestine, testis, and kidney looks very weak, and it is difficult to exclude the possibility that these fluorescences are autofluorescence. The authors should show clearer images and clarify that these fluorescencea are not from autofluorescence.

Response:

We are sorry that the fluorescent photos were blurry and difficult to see. To make the images clearer, we have changed the images to ones that convey our report’s findings more clearly, paying attention to the image resolution and replacing the images with larger versions. If the PDF file created by this revision process also appears blurry, please refer to the “Click here to access~” link in the upper right corner of the PDF file to see the quality of the image submitted to the publisher. This link will take you to the images that have been submitted to the publisher.

The mentioned images of brown adipose tissue, liver, intestines, testes, and kidneys have been replaced with images that show the fluorescence more clearly (Fig 2). The description of the scale bar has been changed because it the original photos have been replaced with larger images. Line 211 has also been changed as follows: “The scale bars represent 50 μm in (B), (B’), (C), (C’), (E), (E’), (I) and (I’) and 100 μm in all the other panels” (Lines 246-248).

4. In Fig.2, which white adipose tissue depot was used? gWAT? iWAT?

Response:

Thank you for pointing this out. gWAT was used in Fig 2. We have added the following sentence: “The tdTomato signal (red) was found in gonadal white (A) and brown (B) adipocytes” (Line 242).

5. Fig.3. Similar to the case of Fig.2, tdTomato-derived fluorescence in some images is very weak and blurry (Fig 3A and 3B).

Response:

We have replaced the image with a clearer version (Fig. 3A and 3B). In Fig. 3A, we have changed the image to show the membranous structure that captures gWAT and the cells that enter the adipose tissue from the capsule surrounding gWAT more clearly. Figure 3B is a highly magnified image of Fig. 3A. For this reason, the description of Fig. 3B at Line 225 has been deleted.

6. Fig.3. From the images of 3C, 3D, it looks like a very limited number of adipocytes are tdTomato positive (Meflin-expressing lineage cells). However, in Fig 3E and 3F, approximately half of the adipocytes are GFP positive, suggesting that these cells are Meflin-expressing lineage cells. The authors should explain this discrepancy.

Response:

Thank you for your comment. The apparent discrepancy in the results shown in Figure 3C, D and E, and F is caused by a difference in the reporter mice that were used. Mature adipocytes can be detected more clearly using membrane-bound EGFP than using cytosolic tdTomato because the cytoplasmic area of mature adipocyte is relatively small. On the other hand, since the proportion of the cytoplasmic area of stromal cells is larger than that of mature adipocytes, stromal cells can be more clearly detected in tdTomato mice.

7. L238, the author mentioned “Meflin-expressing lineage cells differentiate into mature adipocytes that constitute CLS”. However, they also showed that tdTomato-expressing cells in CLS also express F4/80, suggesting that Meflin-expressing lineage cells in CLS are macrophages. Therefore, the authors should clarify whether Meflin-expressing lineage cells in CLS are adipocytes or macrophages.

Response:

Thank you for a very important question. Since it is generally accepted that macrophages are the major cell type constituting the CLS, it is very important to determine whether Meflin lineage tdTomato-positive cells at the CLS are adipocytes, macrophages, or preadipocytes. Thus, we purified tdTomato-positive cells using flow cytometry and examined the gene expressions of adiponectin, F4/80 and Pdgfra. However, the number of tdTomato cells was so small that we were unable to detect the expression of these genes. Thus, we cannot determine the identity of the tdTomato+ cells. Thus, we have corrected Line 238 as follows: “These results suggest that in adult adipose tissues in animals fed an HFD, Meflin lineage cells constitute the CLS. However, whether these cells are adipocytes, macrophages or preadipocytes remains unknown” (Lines 277-280).

8. L261, “Fig 3C” should be “Fig 3D”.

Response:

You are absolutely right. I have corrected this mistake.

9. Fig.4B. Similar to the case of Fig.2, tdTomato-derived fluorescence is too weak and blurry to judge whether these cells are tdTomato positive.

Response:

Figure 4B has been replaced with a clearer image.

10. Fig.4. There is only one beige adipocyte in these images, and it is difficult to judge whether all beige adipocytes are derived from Meflin-expressing lineage cells. Thus, the authors should show images containing many beige adipocytes at a low magnification.

Response:

Thank you for pointing this out. To show multiple beige adipocytes, the previous whole mount image shown in Fig 4A has been replaced with a low magnification image of beige adipocytes. Therefore, Lines 267-269 of the manuscript have been deleted. We have corrected Lines 278-283 as follows: “(A, A’) Immunostaining image shows tdTomato (red)- and UCP1 (green)-positive cell masses. (B, B’) Magnified images of A and A’. The cells in the center have the morphological characteristics of beige adipocytes. Scale bars represent 100 μm in (A) and (A’) and 50 μm in (B) and (B’). A, B: merged (UCP1 + tdTomato + DAPI), A’, B’:tdTomato.” (Lines 321-325).

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Nobuyuki Takahashi

24 Feb 2021

Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissue

PONE-D-20-35143R1

Dear Dr. Tobe,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nobuyuki Takahashi, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments:

Authors addressed all of the Reviewers' comments in this revised manuscript.

Acceptance letter

Nobuyuki Takahashi

1 Mar 2021

PONE-D-20-35143R1

Generation and characterization of a Meflin-CreERT2 transgenic line for lineage tracing in white adipose tissue

Dear Dr. Tobe:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nobuyuki Takahashi

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig

    A. Meflin mRNA levels in the gonadal WAT (n = 4–5). B. QPCR of mesenchymal stem cell related genes in gonadal white adipose tissues of mice treated with normal diet (ND) or high-fat diet (HFD) for 8weeks (n = 4–5). *p < 0.05 by unpaired, 2-tailed t test. C. QPCR of mesenchymal stem cell related genes in inguinal white adipose tissues of mice treated with room temperature (RT) or cold stimulation (Cold) (n = 3–4). D. QPCR of inflammation related genes in gonadal white adipose tissues of mice treated with normal diet (ND) or high-fat diet (HFD) for 8weeks (n = 4–5). E. Oral glucose tolerance test (OGTT) of HFD-fed mice for 8 weeks with the transgenic allele (n = 6) or WT allele (n = 5). F. Insulin tolerance test (ITT) of HFD-fed mice for 8 weeks with the transgenic allele (n = 3) or WT allele (n = 4). G. The Crown like structure were consisted of the cells expressing tdTomato and F4/80. Meflin-CreERT2/Rosa26-tdTomato mice were fed a high-fat diet for 8 weeks and gonadal WAT (gWAT) samples were examined. Meflin lineage cells expressed tdTomato (red) and F4/80 (green). F4/80 is a mature macrophage marker. Nuclei were stained by DAPI (blue). Scale bars represent 50 μm.

    (TIF)

    S1 Table. Primers used for qPCR analyses.

    (PDF)

    S1 Raw images

    (PDF)

    Attachment

    Submitted filename: Response to reviewers.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES